Acne Eczema Rosacea How to Actually Stick to Your Skincare Routine So you started a new skincare routine. You cleaned your mirror for peak admiration of results, popped open each bottle with vim and vigor, and slathered on your products with... 06 February 2025
Successful Treatment of Chronic Staphylococcus aureus-Related Dermatoses with theTopical Endolysin Staphefekt SA.100: A Report of 3 Cases This publication describes 3 cases where patients with chronic and recurrent S. aureus-related dermatoses were successfully treated with Staphefekt SA.100, the active ingredient of Gladskin. The results indicate that targeted... 19 September 2017
Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis This study shows that the skin-microbiome in patients with eczema/atopic dermatitis is characterized by overgrowth of S. aureus bacteria. More overgrowth was linked to more severe symptoms. On the other hand a... 20 June 2017
Staphefekt – intervening early in the Colonisation Infection Continuum with endolysins With Staphefekt, the first targeted therapy against S. aureus is available for long-term daily maintenance therapy, aimed at decreasing the burden of skin colonisation and preventing progression to inflammation and... 20 June 2016
Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta-analysis These results demonstrate the importance of colonization with S. aureus in Atopic Dermatitis... At present, new targeted antimicrobial therapies (such as lysins) are being developed, which are directed against single... 20 June 2016
Micreos' chief medical officer talks to EPM about antibiotic alternatives. Johan Frieling has recently been appointed as the new chief medical officer of Micreos. EPM talks to him about his experience in the pharmaceutical sector and the company’s new antibiotic... 19 May 2016
Staphefekt is featured in The Biomedical Scientist as being the first effective alternative to antibiotics for suppression of S. aureus on the skin. The endolysin Staphefekt is the active ingredient of Gladskin products and it could play a big role in the maintenance treatment of chronic skin conditions where bacteria are thought to... 23 October 2015
